Positions

Overview

  • Dr. Marrazzo is Professor of Medicine and Director of the Division of Infectious Diseases at the University of Alabama at Birmingham. She is internationally recognized for her research and education efforts in the field of sexually transmitted infections, especially as they affect women’s health. She is a Fellow of the American College of Physicians and of the Infectious Diseases Society of America. Dr. Marrazzo has chaired the American Board of Internal Medicine (ABIM) Council, and the ABIM Infectious Disease Specialty Board. She is board certified in Infectious Disease.
    She conducts research on the human microbiome, specifically as it relates to female reproductive tract infections and hormonal contraception. Her other research interests include prevention of HIV infection using biomedical interventions, including PrEP and microbicides. Other research interests include pathogenesis and management of bacterial vaginosis, sexually transmitted diseases in HIV-infected persons, and management of antibiotic resistance in gonorrhea.

    • Selected Publications

    Academic Article

    Year Title Altmetric
    2020 Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities 2020
    2020 ECHO: context and limitations 2020
    2019 Social harms in female-initiated HIV prevention method research: State of the evidence 2019
    2019 Tenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis in sexually active women: a phase 1, single-blind, randomised, controlled trial 2019
    2019 Recent Developments in Biomedical Issues in Sexually Transmitted Infections: Implications for Behavioral Parameters of Interest 2019
    2019 Tenofovir gel for prevention of herpes simplex virus type 2 acquisition: Findings from the VOICE trial 2019
    2019 The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission 2019
    2019 Safety and efficacy of a novel vaginal anti-infective, TOL-463, in the treatment of bacterial vaginosis and vulvovaginal candidiasis: A randomized, single-blind, phase 2, controlled trial 2019
    2019 HIV status and other risk factors for prevalent and incident sexually transmitted infection during pregnancy (2000-2014) 2019
    2018 Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea 2018
    2018 PrEParing Women to Prevent HIV: An Integrated Theoretical Framework to PrEP Black Women in the United States 2018
    2018 Sexually Transmitted Infection Prevalence in Women with HIV: Is There a Role for Targeted Screening? 2018
    2018 Health Care Provider Perceptions of a Sexually Transmitted Infection Self-testing Program in an HIV Care Clinic 2018
    2018 Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women 2018
    2018 BIOMEDICAL PREVENTION OF HIV IN WOMEN: CHALLENGES AND APPROACHES, WITH PARTICULAR REFERENCE TO THE VAGINAL MICROBIOME 2018
    2018 Sexually transmitted infections in the era of antiretroviral-based HIV prevention: Priorities for discovery research, implementation science, and community involvement 2018
    2017 The fourth generation AlereTM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples 2017
    2017 Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations 2017
    2017 HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights 2017
    2017 Sexually transmitted infections: challenges ahead 2017
    2017 Contraceptive Use and Pregnancy Incidence among Women Participating in an HIV Prevention Trial 2017
    2017 Prevention of Sexually Transmitted Diseases in HIV-Infected Individuals 2017
    2017 Validity of self-reported history of Chlamydia trachomatis infection 2017
    2017 Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women 2017
    2017 Risk Factors for Incidence of Sexually Transmitted Infections among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003) 2017
    2017 Diversity in the US Infectious Diseases Workforce: Challenges for Women and Underrepresented Minorities 2017
    2016 A conversation among the IAS–USA board of directors: Hot topics and emerging data in HIV research and care 2016
    2016 A conversation among the IAS–USA board of directors: Hot topics and emerging data in HIV research and care 2016
    2016 HIV prevention: Opportunities and challenges 2016
    2016 HIV prevention: Opportunities and challenges 2016
    2016 Ocular Syphilis: a Clinical Review 2016
    2016 Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit? 2016
    2016 More Easily Cultivated Than Identified: Classical Isolation with Molecular Identification of Vaginal Bacteria 2016
    2016 The Vaginal Microbiome: Current Understanding and Future Directions 2016
    2016 Variations in Clinical Presentation of Ocular Syphilis: Case Series Reported from a Growing Epidemic in the United States 2016
    2016 An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women 2016
    2016 Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection 2016
    2016 Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay 2016
    2016 Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study 2016
    2016 Pharmacological measures of treatment adherence and risk of HIV infection in the VOICE study 2016
    2016 Bone mineral density changes among young, healthy African women receiving oral tenofovir for HIV preexposure prophylaxis 2016
    2015 Disclosure of pharmacokinetic drug results to understand nonadherence 2015
    2015 Barriers to bacterial sexually transmitted infection testing of HIV-infected men who have sex with men engaged in HIV primary care 2015
    2015 Levels of Genital Tract Defensins and Cytokines Differ between HIV-Uninfected US and African Women 2015
    2015 Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women 2015
    2015 Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply. 2015
    2015 Syphilis? An Unusual Cause of Surgical Emergency in a Human Immunodeficiency Virus-Infected Man. 2015
    2015 A phase 3, multicenter, randomized, double-blind, vehicle-controlled study evaluating the safety and efficacy of metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis 2015
    2015 Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: A prospective cohort study 2015
    2015 Women who have sex with women living in low- and middle-income countries: A systematic review of sexual health and risk behaviors 2015
    2015 Perceptions and Experiences with the VOICE Adherence Strengthening Program (VASP) in the MTN-003 Trial 2015
    2015 Metabolic signatures of bacterial vaginosis 2015
    2015 Tenofovir-based preexposure prophylaxis for HIV infection among African women 2015
    2015 A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds 2015
    2015 Advancing care for lesbian, gay, bisexual, and transgender persons: Enough already? 2015
    2015 Factors associated with bone mineral density in healthy African women 2015
    2015 Oral and vaginal tenofovir for genital herpes simplex virus type 2 shedding in immunocompetent women: A double-blind, randomized, cross-over trial 2015
    2015 Rapid and profound shifts in the vaginal microbiota following antibiotic treatment for bacterial vaginosis 2015
    2015 Relationship of specific bacteria in the cervical and vaginal microbiotas with cervicitis 2015
    2015 Tenofovir-based preexposure prophylaxis for HIV infection among African women 2015
    2015 What's new in sexually transmitted infections in the hiv care setting: Focus on syphilis and gonorrhea 2015
    2014 Recent advances in understanding and managing Chlamydia trachomatis infections 2014
    2014 Review: Self-collected samples are less accurate for HPV testing than cliniciancollected samples 2014
    2014 Antiviral activity of genital tract secretions after oral or topical tenofovir pre-exposure prophylaxis for HIV-1 2014
    2014 Addressing standards of care in resource-limited settings 2014
    2014 Bacterial Vaginosis and the Cervicovaginal Immune Response 2014
    2014 Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR (Journal of Clinical Microbiology (2009) 47, 3, (721-726)) 2014
    2014 HIV prevention in clinical care settings: 2014 Recommendations of the International Antiviral Society-USA Panel 2014
    2014 Improving HIV/STD prevention in the care of persons living with HIV through a national training program 2014
    2013 Bacterial vaginosis-associated bacteria in men: Association of Leptotrichia/Sneathia spp. with nongonococcal urethritis 2013
    2013 Introduction to the special issue highlighting Anaerobe 2012 2013
    2013 Screening and management of genital chlamydial infections 2013
    2013 Sexually transmitted infections 2013
    2013 More Than Meets the Eye: Associations of Vaginal Bacteria with Gram Stain Morphotypes Using Molecular Phylogenetic Analysis 2013
    2013 Population-Level Benefits from Providing Effective HIV Prevention Means to Pregnant Women in High Prevalence Settings 2013
    2013 A prospective cohort study comparing the effect of single-dose 2 G metronidazole on trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women 2013
    2013 Performance of the cepheid CT/NG Xpert rapid PCR test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae 2013
    2013 Vaginal biofilms and bacterial vaginosis: Of mice and women 2013
    2013 American sexually transmitted diseases association and the thomas parran award: Past, present, and future 2013
    2013 Editorial Commentary: Sexual networks, sex hormones, and recurrent bacterial vaginosis: Not such strange bedfellows 2013
    2012 Mucosal escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial 2012
    2012 Behavioral predictors of colonization with lactobacillus crispatus or Lactobacillus jensenii after treatment for bacterial vaginosis: A cohort study 2012
    2012 Bacterial communities in women with bacterial vaginosis: High resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria 2012
    2012 Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis 2012
    2012 The posttrial effect of oral periodic presumptive treatment for vaginal infections on the incidence of bacterial vaginosis and lactobacillus colonization 2012
    2012 Emerging sexual health issues among women who have sex with women 2012
    2012 Chlamydia positivity in women screened in family planning clinics: Racial/ethnic differences and trends in the Northwest U.S., 1997-2006 2012
    2011 Interventions to prevent sexually transmitted infections, including HIV infection 2011
    2011 Sexually transmitted infections among women who have sex with women 2011
    2011 Effect of sexual activity on vaginal colonization with hydrogen peroxide-producing lactobacilli and gardnerella vaginalis 2011
    2011 Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators 2011
    2011 A behavioural intervention to reduce persistence of bacterial vaginosis among women who report sex with women: Results of a randomised trial 2011
    2011 Interpreting the epidemiology and natural history of bacterial vaginosis: Are we still confused? 2011
    2011 Establishing and sustaining a healthy vaginal environment: Analysis of data from a randomized trial of periodic presumptive treatment for vaginal infections 2011
    2011 Chlamydia trachomatis infection among women reporting sexual activity with women screened in family planning clinics in the Pacific Northwest, 1997 to 2005 2011
    2010 Bacterial vaginosis: Identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID 2010
    2010 Antiretroviral-based HIV prevention strategies for women 2010
    2010 Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis 2010
    2010 Risks for acquisition of Bacterial vaginosis among women who report sex with women: A cohort study 2010
    2010 Even NHANES evolves: Some surprising findings about women who have sex with women 2010
    2010 Prevalence and risks for bacterial vaginosis in women who have sex with women 2010
    2010 Walter E. Stamm, MD, 1945-2009 2010
    2009 Preferred characteristics of vaginal microbicides in women with bacterial vaginosis 2009
    2009 Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR 2009
    2009 Distribution of genital Lactobacillus strains shared by female sex partners 2009
    2009 Sexually transmitted infections and associated conditions among women who have sex with women 2009
    2008 Chlamydia positivity in american Indian/Alaska native women screened in family planning clinics, 1997-2004 2008
    2008 Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis 2008
    2008 Routine HIV testing in the context of syndromic management of sexually transmitted infections: Outcomes of the first phase of a training programme in Botswana 2008
    2008 Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women 2008
    2008 Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis 2008
    2008 Acceptability of urine-based screening for Chlamydia trachomatis in asymptomatic young men: a systematic review. 2008
    2008 The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature. 2008
    2008 The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women. 2008
    2007 Emerging issues in management of sexually transmitted diseases in HIV infection 2007
    2007 Population-based outreach for chlamydia screening in men: Results from a randomized trial 2007
    2007 Expanding the spectrum of pathogens in urethritis: Implications for presumptive therapy? 2007
    2007 Elusive aetiology of bacterial vaginosis. Do lesbians have a clue? 2007
    2007 Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis 2007
    2007 Within the hidden epidemic: Sexually transmitted diseases and HIV/AIDS among American Indians and Alaska natives 2007
    2007 Selective testing criteria for gonorrhea among young women screened for chlamydial infection: Contribution of race and geographic prevalence 2007
    2007 Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: A randomized controlled trial 2007
    2007 Management of women with cervicitis 2007
    2007 Acceptability of urine-based screening for Chlamydia trachomatis to asymptomatic young men and their providers 2007
    2007 Superficial hepatic capsular lesions in a systemically ill young woman 2007
    2007 Correlates of sexually transmitted infections in young women [1] 2007
    2007 Syphilis and other sexually transmitted diseases in HIV infection. 2007
    2006 Reply to Forney et al. [4] 2006
    2006 Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis 2006
    2006 A persistent(ly) enigmatic ecological mystery: Bacterial vaginosis 2006
    2006 Prevalence of Neisseria gonorrhoeae among men screened for Chlamydia trachomatis in four United States Cities, 1999-2003 2006
    2006 Risk factors for cervicitis among women with bacterial vaginosis 2006
    2006 Chlamydial infections among female adolescents screened in juvenile detention centers in Washington State, 1998-2002 2006
    2006 The authors reply [2] 2006
    2005 Molecular identification of bacteria associated with bacterial vaginosis 2005
    2005 Cervical specimen order and performance measures of Chlamydia trachomatis diagnostic testing 2005
    2005 Dangerous assumptions: Lesbians and sexual death 2005
    2005 Sexual practices, risk perception and knowledge of sexually transmitted disease risk among lesbian and bisexual women 2005
    2005 Impact of patient characteristics on performance of nucleic acid amplification tests and DNA probe for detection of Chlamydia trachomatis in women with genital infections 2005
    2005 Prevalence of Chlamydia trachomatis infection among men screened in 4 U.S. cities 2005
    2005 Molecular methodology in determining vaginal flora in health and disease: Its time has come 2005
    2005 Mucopurulent cervicitis: No longer ignored, but still misunderstood 2005
    2005 Sexual tourism: Implications for travelers and the destination culture 2005
    2004 Barriers to infectious disease care among lesbians. 2004
    2004 Re-evaluating Selective Screening Criteria for Chlamydial Infection among Women in the U.S. Pacific Northwest 2004
    2004 Evolving issues in understanding and treating bacterial vaginosis 2004
    2004 Lesbian Health Matters: A Pap Test Education Campaign Nearly Thwarted by Discrimination 2004
    2004 Reproductive health history of lesbians: Implications for care 2004
    2004 Sexually transmitted diseases in the HIV care setting: what's really going on down there? 2004
    2003 Prevalence and Risk Factors for Infection with Herpes Simplex Virus Type-1 and -2 among Lesbians 2003
    2003 Functional characterization of class Ia- and non-class Ia-restricted Chlamydia-reactive CD8+ T cell responses in humans 2003
    2003 Vulvovaginal candidiasis 2003
    2003 Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: A systematic review 2003
    2003 The clinical and economic consequences of screening young men for genital chlamydial infection 2003
    2003 Candidiasis (vulvovaginal). 2003
    2003 Chlamydia trachomatis infection in asymptomatic men 2003
    2002 Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard 2002
    2002 Extracts from "Concise Clinical Evidence": Vulvovaginal candidiasis 2002
    2002 Predicting chlamydial and gonococcal cervical infection: Implications for management of cervicitis 2002
    2002 Characterization of vaginal flora and bacterial vaginosis in women who have sex with women 2002
    2002 Vulvovaginal candidiasis. 2002
    2002 Vulvovaginal candidiasis. 2002
    2001 Erratum: The relative increase in prevalence using LCR was highest among men with < 5 polymorphonuclear leukocytes per high-power (1000×) field (PMN/HPF) on urethral Gram stain regardless of symptoms, and in symptomatic men with gonorrhea diagnosed by urethral culture (Sexually Transmitted Diseases 28:4 (220)) 2001
    2001 Impact of New Sexually Transmitted Disease Diagnostics on Clinical Practice and Public Health Policy. 2001
    2001 Characteristics of female sexually transmitted disease clinic clients who report same-sex behaviour 2001
    2001 Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women 2001
    2001 Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics 2001
    2000 Sexually transmitted infections in women who have sex with women: Who cares? 2000
    2000 Genital human papillomavirus infection in women who have sex with women: A concern for patients and providers 2000
    2000 Genital human papillomavirus infection in women who have sex with women: A review 2000
    1998 Genital human papillomavirus infection in women who have sex with women 1998
    1998 New approaches to the diagnosis, treatment, and prevention of chlamydial infection 1998
    1997 Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay 1997
    1997 Selective screening for chlamydial infection in women: A comparison of three sets of criteria 1997
    1997 Selective screening for chlamydial infection in women: A comparison of three sets of criteria 1997
    1997 Cesarean delivery in women with genital herpes in washington state, 1989-1991. 1997
    1997 Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: Implications for a national chlamydia control strategy 1997
    1995 Chancroid: new developments in an old disease. 1995

    Chapter

    Year Title Altmetric
    2014 Neisseria gonorrhoeae (Gonorrhea).  2446-2462.e3. 2014
    2013 Bacterial Vaginosis.  463-498. 2013
    2013 Syphilis in Women.  461-471. 2013
    2013 Topical Microbicides for Human Immunodeficiency Virus and Sexually Transmitted Disease Prevention.  213-227. 2013
    2013 Chlamydia trachomatis infection among sexual minorities.  142-150. 2013
    2013 Enhancing women's sexual health: Prevention measures in diverse populations of women.  197-219. 2013
    2012 Bacterial Vaginosis.  54-63. 2012
    2012 Introduction to Sexually Transmitted Infections.  300-302. 2012
    2001 Chlamydiae.  795-822. 2001

    Research Overview

  • Effects of contraceptive ring on vaginal microbiota, HIV shedding and local immunity
    Optimizing Vaginal Ring Pre-Exposure Prophylaxis for HIV
    The Genital Microbiome as a Determinant of Sexual Health & Local Immunity
    The Role of Uncultivated Bacteria in Bacterial Vaginosis
    Vaginal and oral pre-exposure prophylaxis to prevent HIV and HSV-2 infection in women

    • Principal Investigator On

  • UAB Center for AIDS Research -SWG Core - Ending HIV in Alabama SWG  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2024
  • Private Grant  awarded by BECTON DICKINSON AND COMPANY 2019 - 2022
  • 75N93019F00131 TA02 TO9 Development of a Protocol, Clinical Trial Implementation, Closeout and Analysis of a Phase 2 Clinical Trial to Evaluate the Eficacy of rMenB+OMV NZ (Bexsero, GSK) in Preventing Neisseria Gonorrhoese Infection  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2021
  • 75N93019F00132 TA1 TO15 Overall Administrative and Support Activities for the STI CTG to Include Procedures to Identify, Discuss, and Develop Scientific Concepts  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2021
  • Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2021
  • T011 HHSN27200010 TA1 TO9 Protocol Development, Implementation and Analysis for Mycoplasma Genitalium Among Men with Urethritis Attending STD Clinics in the US: Assessing Burden, Risk Factors and Co-Infections  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2021
  • T012 HHSN27200011 TA1 TO10 Protocol Development, Implementation and Analysis for Treatment of Gardnerella Vaginalis Vaginal Colonization with Amoxicillin  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2021
  • T013 HHSN27200012 TA1 TO11 Overall Admin and Support Activities for the STI CTG to Include Procedures to Identify, Discuss and Develop Scientific Concepts  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2021
  • T015 HHSN27200013 TA2 TO7 Protocol Development, Implementation and Analysis for a Randomized Controlled Trial of Azithromycin Versus Doxycycline for the Treatment of Rectal Chlamydia in Men who have Sex with Men  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2021
  • T016 HHSN27200014 TA2 TO8 A Phase III Comparative Trial of Benzathine Penicillin G, 2.4 Million Units Administered as a Single Dose Versus Three Sucessive Weekly Doses for Treatment of Early Syphilis in Persons with and without HIV  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2021
  • T017 HHSN27200015 TA1 TO13 Protocol Development, Implementation and Analysis for Development and Validating an Easy to Administer Instrument to Define Penicillin (B-lactam) Allergy Status in STD Outpatients  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2021
  • T018 HHSN27200016 TA1 TO14 A Randomized, Placebo-Controlled Trial of TOL-463 for Suppression of Bacterial Vaginosis (BV)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2021
  • Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)  awarded by Emory University 2019 - 2020
  • Leadership and Operations Center (LOC): Microbicide Trials Network  awarded by Magee-Womens Research Institute (MWRI) 2016 - 2020
  • STI & HIV 2019 World Congress, The Joint Meeting of the 23rd International Society for Sexually Transmitted Disease Research (ISSTDR) & 20th International Union Against Sexually Transmitted Infections (IUSTI)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2020
  • The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC) - Core A-Administrative Core  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2020
  • The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2018 - 2020
  • Private Grant  awarded by CEPHEID 2018 - 2019
  • University of Washington Sexually Transmitted Infections Cooperative Research Cen  awarded by UNIVERSITY OF WASHINGTON 2016 - 2019
  • 14th Biennial Congress of the Anaerobe Society of the Americas (ASA)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2018 - 2019
  • Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2016 - 2019
  • Drug at the Right Place and Concentration: Optimizing Combination Vaginal Ring PrEP  awarded by ALBERT EINSTEIN COLLEGE OF MEDICINE 2016 - 2018
  • Seattle STD Clinical Prevention Training Center  awarded by UNIVERSITY OF WASHINGTON 2016 - 2018

    • Investigator On

  • UAB Center for AIDS Research (CFAR)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2024
  • UAB Center for AIDS Research - Administrative Core  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2024
  • Increasing Uptake of PrEP in Urban and Rural Black Women in the South  awarded by Johnson (Robert Wood) Foundation 2018 - 2021
  • A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults  awarded by Emory University 2020 - 2021
  • Private Grant  awarded by RHEONIX, INC. 2014 - 2020
  • Private Grant  awarded by ABBOTT MOLECULAR 2018 - 2020
  • HHSN27200012 Task Area 1 Task Order 11 - Overall Admin and Support Activities for the STI CTG to Include Procedures to Identify, Discuss and Develop Scientific Concepts  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • HHSN27200016 TA1 TO 14 Task Area 1 Task Order 14: A Randomized, Placebo-Controlled Trial of TOL-463 for Suppression of Bacterial Vaginosis (BV)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2020
  • The UAB STI CRC - DiSCIS Administrative Core  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2020
  • The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019

    • Teaching Overview

  • Dr. Marrazzo lectures on topics related to vaginal health and sexually transmitted infections.

    • Education And Training

  • Master of Public Health in Epidemiology, University of Washington 1994
  • Doctor of Medicine, Thomas Jefferson University 1988
  • Bachelor of Arts in Biology, Harvard University 1984
  • Yale-New Haven Hospital, Internship 1989
  • Yale-New Haven Hospital, Residency 1991
  • University of Washington, Postdoctoral Fellowship 1995

    • Full Name

  • Jeanne Marrazzo